about
Arginine deprivation therapy for malignant melanomaA common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions.Biocompatible materials for continuous glucose monitoring devicesRedox balance dynamically regulates vascular growth and remodelingNonthermal electromagnetic fields: from first messenger to therapeutic applicationsMechanistic exploration of phthalimide neovascular factor 1 using network analysis tools.Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.Pharmacotherapy for end-stage coronary artery disease.In vivo analytical performance of nitric oxide-releasing glucose biosensors.Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells.Pathological aspects of lipid peroxidation.Applications of chitin and its derivatives in biological medicine.Nitric oxide-releasing electrospun polymer microfibers.Stöber Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles.DDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesis.Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.The emerging role of the thioredoxin system in angiogenesisProinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease.Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance.Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.Clinical translation of nitrite therapy for cardiovascular diseases.Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice.Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transportersNitric oxide and adult neurogenesis in health and disease.LDL biochemical modifications: a link between atherosclerosis and aging.ADMA: its role in vascular disease.ADMA metabolism and clearance.Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release.The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin.Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesisSystemic ghrelin administration alters serum biomarkers of angiogenesis in diet-induced obese mice.Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.The effect of nitric oxide surface flux on the foreign body response to subcutaneous implants.Systems Pharmacology Uncovers the Multiple Mechanisms of Xijiao Dihuang Decoction for the Treatment of Viral Hemorrhagic FeverCD47: a new target in cardiovascular therapy.
P2860
Q24634269-A3564AD4-7B03-4E61-9172-12051492412EQ24817217-B0ECB9DB-C622-4830-B6EF-E8D8B80F5352Q26823654-5828E55B-FB95-4EE1-94B0-DF2FF2F33C4DQ27004547-D4BCFF80-C35C-4BA7-8CD6-0857D7EA8178Q28290660-AA209A7F-4815-49D4-9545-0E6D3F80C332Q30431758-DD91F927-8667-4CD4-BAEA-17CBC4207504Q33522876-64DDFA17-03FC-4867-8C78-50B40BBD30F9Q33589158-B02038DA-D298-4E14-80BE-94E67259F1B9Q33610142-C37F4A8E-F731-4918-89F5-10DF494F6EAFQ33975314-D5C69D58-BE4A-410D-A332-EBC32153C0CFQ33990716-6B399CE0-DE69-4D58-A828-9AA5E92B709EQ34012826-12BAF86B-B80F-4BD0-81D1-86A1EDFE4933Q34137628-0880B1B3-1D0A-45AB-A13A-DC8B577C79D3Q34187459-166E25E7-789C-4B65-948C-0EA93D919143Q34608579-16DB8AB2-B552-4DEA-A88E-A36C6A12F0E1Q34784911-89222CD9-AD0B-43B5-A03C-E21C1AE3D020Q35048434-3EEA8BB7-1B23-4B0F-BD00-7CE7C06EFF68Q35090446-B70EBC91-EBE0-4E9D-B072-1C55D5E2019CQ35123800-5B80E5F1-9BC2-4DB1-8549-6A6758650646Q35220258-54DE44ED-2621-4555-91A7-209889405FF7Q35540671-CD5C6A1A-80BD-444F-B754-F2A01076E735Q35642769-05EC3818-B007-4274-A42D-908DE5FF85E2Q35686746-872B0744-808A-4838-985A-D419680A579EQ35917666-46A08366-1684-4CA4-BFD3-C2B8DC6DDC30Q36040865-CE7313F9-EA45-461D-A4AF-1446EAE360BCQ36060627-4432C8BF-8EE7-4EC8-A807-78870A231EE7Q36170493-564C6F40-C70B-4FC1-9EBC-04A371630F4EQ36215211-F032366D-B217-455D-80D6-0B0768F3EE0AQ36348442-020EA3AA-F50B-476B-9573-836B46D61023Q36380994-AC49B1CD-6306-4A65-ADDA-C7A79C8EF1D7Q36381017-F300EE18-72DE-428E-9843-D5D7A4709279Q36525422-A8BA6658-3C76-4208-A14E-78587C775BEEQ36648000-EA3BA586-BCE9-4FE2-AD8B-87E66E6CA052Q36676815-7930E9AF-1B41-4E7B-83C5-A88991CE190AQ36702510-14F6078C-9799-4F30-AE84-9B95FB2734AAQ36725128-038F705C-2473-45CF-944F-F973721D155EQ36831934-0EEF2273-A630-4E1E-AF1B-56E48F08FA69Q36886778-E1B97A16-20F4-4FAF-B4D2-D50E4AA3C8D3Q36889767-41B2032E-BD5B-463B-B6D1-498A10630B53Q36908751-D6D928B8-5060-4AAC-B436-2F463A0D99C9
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
NO and angiogenesis.
@ast
NO and angiogenesis.
@en
type
label
NO and angiogenesis.
@ast
NO and angiogenesis.
@en
prefLabel
NO and angiogenesis.
@ast
NO and angiogenesis.
@en
P1476
NO and angiogenesis.
@en
P2093
John P Cooke
P356
10.1016/S1567-5688(03)00034-5
P577
2003-12-01T00:00:00Z